You can narrow down the results using the filters
This document provides baseline information about the parent organism for use in risk analysis of genetically modified carnation that may be released into the Australian environment.
The overall finding of the 2019 survey is that attitudes to genetically modified organisms (GMOs) have moved more towards neutral middle positions, as well as an increase in those who aren’t sure or don’t know, and some reduction in those with stronger views.
This Communique covers matters considered at the 13th meeting of the Gene Technology Ethics and Community Consultative Committee (19 November 2019, Canberra).
IBCs can use this model form when making an NLRD record of assessment (RoA) and recording that it has been given to the proponent.
The report describes the roles and responsibilities of the Gene Technology Regulator (the Regulator) and the Office of the Gene Technology Regulator (OGTR) during 2018-19.
This documents helps with the correct classification of NLRDs being included in the Record of Assessment for reporting online.
This document provides baseline information about the parent organism for use in the risk analysis of genetically modified (GM) N. oceanica that may be released into the Australian environment.
This document provides baseline information about the parent organism for use in risk assessments of genetically modified (GM) C. tinctorius that may be released into the Australian environment.
This is an excerpt from the Gene Technology Regulations 2001 incorporating amendments from Schedule 1 of the Gene Technology Amendment (2019 Measures No. 1) Regulations 2019, which commence on 8 October 2019.
Schedule 3 of the Gene Technology Regulations 2001 describes the types of dealings with GMOs that are classified as NLRDs. This is an excerpt from the regulations incorporating amendments which commence on 8 October 2019.
Guidance for IBCs: Regulatory requirements for contained research with GMOs containing engineered gene drives
This document provides guidance for Institutional Biosafety Committees (IBCs) and researchers on the regulatory requirements for organisms containing engineered ‘gene drives’, including the physical containment (PC) level of facilities for notifiable low risk dealings (NLRDs).
Look-up tables for classification of contained dealings with viral vectors based on the vector type, characteristics and whether in vitro or in vivo.
This application form must be used for applications for a licence for dealings (activities) NOT involving the intentional release of a GMO into the environment (DNIR).
The purpose of this document is to inform researchers undertaking NLRDs about the Gene Technology Regulator’s (the Regulator’s) operational policy for considering requests to conduct NLRDs in alternate facilities, pursuant to regulation 13(2)(c).
This protocol is to provide inquiring third parties with the appropriate information on how to report matters of non-compliance to the OGTR.
This document describes how the potential risks of regulatory sequences in GM plants are considered when preparing Risk Assessment and Risk Management Plans (RARMPs).